Join the fight against sepsis – invest in life-saving precision medicine at capitalcell.com.
AdrenoMed is revolutionizing sepsis treatment with Enibarcimab, a first-in-class antibody addressing one of the most pressing needs in intensive care: protecting and restoring vascular integrity in critically ill patients. After showing a 67% relative mortality